Pfizer has shown up with data at every major oncology meeting this year. This week is no exception. At #SABCS25, we presented Phase 3 results we believe could establish a new standard of care in HER2+ metastatic breast cancer. Thank you to our teams for delivering.

Tag-uri: Pfizer